Changeflow GovPing Healthcare & Life Sciences Multi-Omics Analysis of Lens Zonule Relaxation ...
Routine Notice Added Final

Multi-Omics Analysis of Lens Zonule Relaxation in PACG Pathogenesis

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

NIH registered observational clinical study NCT07539675 on ClinicalTrials.gov examining differential molecular expression in Primary Angle-Closure Glaucoma patients with zonular laxity compared to those without and controls. The study involves no experimental interventions and seeks to construct a mechanistic network from identified molecules.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

NIH registered a new observational clinical study (NCT07539675) on ClinicalTrials.gov. The study aims to identify differentially expressed molecules in Primary Angle-Closure Glaucoma patients with zonular laxity compared to those without and control groups.

Affected parties include healthcare institutions and clinical researchers studying glaucoma pathogenesis. The study registration has no compliance obligations and does not create regulatory requirements for any party.

Archived snapshot

Apr 20, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

The Multi-Omics Analysis of Lens Zonule Relaxation in The PACG Pathogenesis

Observational NCT07539675 Kind: OBSERVATIONAL Apr 20, 2026

Abstract

Compared with primary angle-closure glaucoma (PACG) patients without zonular laxity and the control group, there are differentially expressed molecules in PACG patients with zonular laxity, and a potential mechanistic network can be constructed therefrom.

Conditions: Primary Angle-Closure Glaucoma

Interventions: No Additional Experimental Intervention

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 20th, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers
Industry sector
6221 Hospitals & Health Systems
Activity scope
Clinical trial registration Observational study Multi-omics research
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Public Health Pharmaceuticals

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!